nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients
|
Sartore-Bianchi, Andrea |
|
2017 |
71 |
C |
p. 43-50 8 p. |
artikel |
2 |
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies
|
Lambertini, Matteo |
|
2017 |
71 |
C |
p. 34-42 9 p. |
artikel |
3 |
Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial
|
Parker, Christopher |
|
2017 |
71 |
C |
p. 1-6 6 p. |
artikel |
4 |
Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain
|
von Moos, Roger |
|
2017 |
71 |
C |
p. 80-94 15 p. |
artikel |
5 |
Locoregional treatment and overall survival of men with T1a,b,cN0M0 breast cancer: A population-based study
|
Leone, José Pablo |
|
2017 |
71 |
C |
p. 7-14 8 p. |
artikel |
6 |
Management of synchronous liver metastases and the recommendations of the second St. Gallen European Organisation for Research and Treatment of Cancer consensus conference on the management of rectal cancer
|
Chan, Anthony K.C. |
|
2017 |
71 |
C |
p. 51-52 2 p. |
artikel |
7 |
Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs
|
Schadendorf, Dirk |
|
2017 |
71 |
C |
p. 53-69 17 p. |
artikel |
8 |
Patient-reported outcomes in ductal carcinoma in situ: A systematic review
|
King, Madeleine T. |
|
2017 |
71 |
C |
p. 95-108 14 p. |
artikel |
9 |
Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide
|
Jamieson, David |
|
2017 |
71 |
C |
p. 15-24 10 p. |
artikel |
10 |
Physical activity and survival in breast cancer: What were missing?
|
Wu, Hong |
|
2017 |
71 |
C |
p. 121-122 2 p. |
artikel |
11 |
Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the Netherlands
|
't Lam-Boer, J. |
|
2017 |
71 |
C |
p. 109-116 8 p. |
artikel |
12 |
Reply to the letter: ‘Physical activity and survival in breast cancer: What were missing?’ by Wu H, Wang D, and Ruan X
|
Ammitzbøll, Gunn |
|
2017 |
71 |
C |
p. 123-124 2 p. |
artikel |
13 |
Reply to the Letter to the Editor concerning ‘High levels of the soluble programmed death-ligand identify hepatocellular carcinoma patients with a poor prognosis’
|
Finkelmeier, Fabian |
|
2017 |
71 |
C |
p. 119-120 2 p. |
artikel |
14 |
Soluble PD-L1 and prognosis of patients with hepatocellular carcinoma
|
Luo, Cheng-Piao |
|
2017 |
71 |
C |
p. 117-118 2 p. |
artikel |
15 |
Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology
|
Lambertini, Matteo |
|
2017 |
71 |
C |
p. 25-33 9 p. |
artikel |
16 |
Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients
|
Loquai, Carmen |
|
2017 |
71 |
C |
p. 70-79 10 p. |
artikel |